Latest KFF Health News Stories
An Arm and a Leg: New Lessons in the Fight for Charity Care
Host Dan Weissmann checks back in on the fight for hospital charity care, with lessons from Dollar For and a savvy listener.
Nursing Homes Fell Behind on Vaccinating Patients for Covid
Last winter, only 4 in 10 nursing home residents got an updated covid vaccine. The low uptake leaves a fragile population vulnerable. Some industry watchdogs say it could be a sign of eroding trust between nursing home residents and providers.
9 States Poised To End Coverage for Millions if Trump Cuts Medicaid Funding
About 3.7 million people are at immediate risk of losing health coverage should the federal government cut funding for Medicaid expansions, as some allies of President-elect Donald Trump have proposed. Coverage could be at risk in the 40 states that have expanded Medicaid.
Si Trump recorta fondos, millones de personas en nueve estados podrían perder Medicaid
Los estados son Arizona, Arkansas, Illinois, Indiana, Montana, New Hampshire, Carolina del Norte, Utah y Virginia.
With Trump on the Way, Advocates Look to States To Pick Up Medical Debt Fight
Patient and consumer advocates fear a new Trump administration will scale back federal efforts to expand financial protections for patients and shield them from debt.
California Falling Short of Enrollment Goal as Mental Health Courts Roll Out Statewide
California’s goal was to help 2,000 seriously mentally ill people by the end of this year, but data shows fewer than 600 petitions have been filed. As the CARE program expands to every county, officials say it sometimes takes months to locate eligible adults and get them in treatment plans.
Nursing Home Industry Wants Trump To Rescind Staffing Mandate
A Biden administration rule that imposed minimum rules on nursing levels may not survive, even though many homes lack enough workers to maintain residents’ care.
Who Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You’re on Medicaid
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients’ weight loss. A look inside the state’s coverage calculus.
¿Podrían los nuevos medicamentos para bajar de peso estar disponibles para todos?
Los medicamentos agonistas GLP-1, conocidos por los nombres comerciales Ozempic, Trulicity y Wegovy, han demostrado ser efectivos para la pérdida de peso y para el manejo de la diabetes tipo 2.
Journalists Dish on New Weight Loss Drugs, RFK Jr.’s Fluoride Claims, and Reproductive Health
KFF Health News staffers and contributors made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Trump Doesn’t Need Congress To Make Abortion Effectively Unavailable
President-elect Donald Trump vowed on the campaign trail not to sign a nationwide abortion ban. But he wouldn’t need to do so to make abortion difficult, or illegal, writes KFF Health News’ chief Washington correspondent, Julie Rovner.
A Toddler Got a Nasal Swab Test but Left Before Seeing a Doctor. The Bill Was $445.
A mom in Peoria, Illinois, took her 3-year-old to the ER one evening last December. While they were waiting to be seen, the toddler seemed better, so they left without seeing a doctor. Then the bill came.
Immigration Detention Center Contractor Sues Over California Health Inspections
A private immigration detention center contractor has sued to block a California law allowing local public health officials to inspect facilities in response to allegations of medical neglect or unsanitary conditions.
Florida’s Deloitte-Run Computer System Cut Off New Moms Entitled to Medicaid
Florida discovered a glitch in its Deloitte-run Medicaid eligibility system. The problem, alleged in court testimony, led to new mothers wrongly losing their insurance coverage.
Indiana Hospitals Pull Merger Application After Pushback Over Monopoly Concerns
Two Indiana hospital rivals withdrew their application to merge after facing pushback from the Federal Trade Commission and the public.
Contratista de centro de detención de inmigrantes demanda a California por inspecciones de salud
GEO Group podría expandir su control sobre las instalaciones de detención de inmigrantes ahora que el ex presidente Donald Trump ganó un segundo mandato.
Journalists Reflect on Trump Picks, Racism and Public Health, and Unnecessary Dental Implants
KFF Health News staff made the rounds on national and local media in the last two weeks to discuss topical stories. Here’s a collection of their appearances.
Georgians With Disabilities Are Still Being Institutionalized, Despite Federal Oversight
For nearly 15 years, the feds have had oversight of Georgia’s treatment of people with mental illness and developmental disabilities. Observers say the state still jeopardizes some of its most marginalized residents by not meeting the terms of its settlement with the Justice Department.
What the Health? From KFF Health News: Trump’s Nontraditional Health Picks
Not only has President-elect Donald Trump chosen prominent vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services, Trump also has said he will nominate controversial TV host Mehmet Oz to run the Centers for Medicare & Medicaid Services, which oversees coverage for nearly half of Americans. Meanwhile, the lame-duck Congress is back in Washington with just a few weeks to figure out how to wrap up work for the year. Rachel Cohrs Zhang of Stat, Sandhya Raman of CQ Roll Call, and Riley Ray Griffin of Bloomberg News join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sarah Varney, who has been covering a trial in Idaho challenging the lack of medical exceptions in that state’s abortion ban.
Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
